Nuveen Asset Management’s Galectin Therapeutics GALT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $35.6K | Hold |
27,623
| – | – | ﹤0.01% | 3320 |
|
|
2024
Q3 | $76K | Hold |
27,623
| – | – | ﹤0.01% | 3320 |
|
|
2024
Q2 | $62.4K | Buy |
+27,623
| New | +$62.4K | ﹤0.01% | 3321 |
|
|
2021
Q2 | – | Sell |
-177,035
| Closed | -$384K | – | 3355 |
|
|
2021
Q1 | $384K | Sell |
177,035
-7,816
| -4% | -$17K | ﹤0.01% | 3133 |
|
|
2020
Q4 | $414K | Buy |
184,851
+2,965
| +2% | +$6.64K | ﹤0.01% | 3081 |
|
|
2020
Q3 | $486K | Sell |
181,886
-57
| -0% | -$152 | ﹤0.01% | 2965 |
|
|
2020
Q2 | $556K | Buy |
181,943
+51,921
| +40% | +$159K | ﹤0.01% | 2856 |
|
|
2020
Q1 | $255K | Buy |
130,022
+22,750
| +21% | +$44.6K | ﹤0.01% | 2948 |
|
|
2019
Q4 | $307K | Sell |
107,272
-14,942
| -12% | -$42.8K | ﹤0.01% | 3003 |
|
|
2019
Q3 | $449K | Buy |
122,214
+41,251
| +51% | +$152K | ﹤0.01% | 2977 |
|
|
2019
Q2 | $336K | Buy |
+80,963
| New | +$336K | ﹤0.01% | 3084 |
|